Improving cervical cancer screening and treatment for HIV positive women in Kenya
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
This study is working to help more women with HIV in Kenya get screened for cervical cancer and connect them to the treatment they need, by improving healthcare access and education in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10931593 on NIH RePORTER |
What this research studies
This research aims to enhance the adoption of cervical cancer screening and improve the linkage to treatment for HIV positive women in Kenya. By addressing the significant gaps in healthcare access and education, the project will implement strategies that involve community engagement and collaboration among various stakeholders, including healthcare providers and government entities. The approach focuses on using implementation science to ensure that effective screening methods are translated into practice, ultimately aiming to reduce late-stage cancer presentations and improve health outcomes for women. The research will also involve training healthcare professionals to better serve this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV positive women living in Kenya who are at risk for cervical cancer.
Not a fit: Patients who are not HIV positive or those who do not reside in Kenya may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of cervical cancer in HIV positive women, significantly improving their health outcomes.
How similar studies have performed: Previous research has shown success in implementing similar screening and treatment linkage programs in other regions, indicating a promising approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.